The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: An in-vitro study

Journal of Orthopaedic Surgery and Research

Volumn 4, Issue 1, 2009, Pages

  Malviya, Ajay ^a   Kuiper, Jan Herman ^b   Makwana, Nilesh ^b   Laing, Patrick ^b   Ashton, Brian ^b  

^a WANSBECK GENERAL HOSPITAL   (United Kingdom)

^b ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68049117091     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/1749-799X-4-17     Document Type: Article

References (39)

1. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing. AJ Busti JS Hooper CJ Amaya S Kazi, Pharmacotherapy 2005 25 11 1566 91 16232020
2. Is methotrexate osteopathy a form of bone idiosyncrasy? AP Rozin, Ann Rheum Dis 2003 62 11 1123 author reply 1124 14583585
3. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. DM Grennan J Gray J Loudon S Fear, Ann Rheum Dis 2001 60 214 217 11171680 (Pubitemid 32260601)
4. In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts. MJ van der Veen BA Scheven JL van Roy CA Damen FP Lafeber JW Bijlsma, Br J Rheumatol 1996 35 4 342 9 8624637
5. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy. R Uehara Y Suzuki Y Ichikawa, J Rheumatol 2001 28 2 251 6 11246658
6. Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage. NJ Minaur C Jefferiss AK Bhalla JN Beresford, Rheumatology (Oxford) 2002 41 7 735 40 12096221
7. In vitro effects of chemotherapeutic agents on human osteoblast-like cells. JH Davies BA Evans ME Jenney JW Gregory, Calcif Tissue Int 2002 70 5 408 15 12055656
8. Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing. LE Dahners BH Mullis, J Am Acad Orthop Surg 2004 12 3 139 43 15161166
9. Cyclooxygenase-2 inhibitor inhibits the fracture healing. K Endo K Sairyo S Komatsubara T Sasa H Egawa D Yonekura K Adachi T Ogawa R Murakami N Yasui, J Physiol Anthropol Appl Human Sci 2002 21 5 235 8 12491820
10. COX-2 selective NSAID decreases bone ingrowth in vivo. S Goodman T Ma M Trindade T Ikenoue I Matsuura N Wong N Fox M Genovese D Regula RL Smith, J Orthop Res 2002 20 6 1164 9 12472224
11. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? M Murnaghan G Li DR Marsh, J Bone Joint Surg Am 2006 88 Suppl 3 140 7 17079380
12. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. LC Gerstenfeld M Al-Ghawas YM Alkhiary DM Cullinane EA Krall JL Fitch, J Bone Joint Surg Am 2007 89 1 114 25 17200318
13. A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats. M Bergenstock W Min AM Simon C Sabatino JP O'Connor, J Orthop Trauma 2005 19 10 717 23 16314720
14. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. AM Simon JP O'Connor, J Bone Joint Surg Am 2007 89 3 500 11 17332098
15. Temporal effects of a COX-2-selective NSAID on bone ingrowth. SB Goodman T Ma L Mitsunaga K Miyanishi MC Genovese RL Smith, J Biomed Mater Res A 2005 72 3 279 87 15666361
16. COX inhibitors and their effects on bone healing. LC Gerstenfeld TA Einhorn, Expert Opin Drug Saf 2004 3 2 131 6 15006719
17. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment? H Pieringer U Stuby G Biesenbach, Semin Arthritis Rheum 2007 36 5 278 86 17204310
18. Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers. PA Rosandich JT Kelley 3rd DL Conn, Curr Opin Rheumatol 2004 16 3 192 8 15103244
19. Isolation and culture of bone-forming cells (osteoblasts) from human bone. J Gallagher R Gundle JN Beresford, Methods in molecular medicine: Human cell culture protocols Totowa: Humana Press Inc, Jones G, 1996 233 262
20. Isolation and culture of human bone-derived cells. R Gundle K Stewart J Screen JN Beresford, Practical animal cell biology series: Marrow stromal cell culture Cambridge: Cambridge University Press, Beresford J, Owen ME, 1998 43 65
21. Human bone-cell proliferation in vitro decreases with human donor age. Y Shigeno BA Ashton, J Bone Joint Surg Br 1995 77 1 139 42 7822372
22. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. LM Jost JM Kirkwood TL Whiteside, Journal of immunological methods 1992 147 2 153 165 1548398
23. Statistics for experimenters. G Box WG Hunter JS Hunter, New York: John Wiley & Sons 2 1978
24. Experiments: Planning, Analysis and Parameter Design Optimization. C Wu MS Hamada, New York: John Wiley & Sons 2000
25. Applied multilevel analysis: a practical guide for medical researchers. JSR Twisk, Cambridge University Press 2006
26. Data analysis using regression and multilevel/hierarchical models. A Gelman J Hill, Cambridge University Press 2006
27. Leflunomide: mode of action in the treatment of rheumatoid arthritis. FC Breedveld JM Dayer, Ann Rheum Dis 2000 59 11 841 9 11053058
28. Involvement of interleukin 1 and tumour necrosis factor alpha as endogenous growth factors in human osteoblastic cells. D Modrowski D Godet PJ Marie, Cytokine 1995 7 7 720 6 8580382
29. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. DG Phinney G Kopen W Righter S Webster N Tremain DJ Prockop, J Cell Biochem 1999 75 3 424 36 10536366
30. Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 14. S Walsh C Jefferiss K Stewart GR Jordan J Screen JN Beresford, Bone 2000 27 2 185 95 10913910
31. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. S Walsh GR Jordan C Jefferiss K Stewart JN Beresford, Rheumatology (Oxford) 2001 40 1 74 83 11157145
32. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. SL Cheng JW Yang L Rifas SF Zhang LV Avioli, Endocrinology 1994 134 1 277 86 8275945
33. RANKL expression is related to the differentiation state of human osteoblasts. GJ Atkins P Kostakis B Pan A Farrugia S Gronthos A Evdokiou K Harrison DM Findlay AC Zannettino, J Bone Miner Res 2003 18 6 1088 98 12817763
34. Pharmacogenetics of disease-modifying anti-rheumatic drugs. E Tanaka A Taniguchi W Urano H Yamanaka N Kamatani, Best Pract Res Clin Rheumatol 2004 18 2 233 47 15121042
35. Assessing combinations of cytotoxic agents using leukemia cell lines. CP Reynolds MH Kang N Keshelava BJ Maurer, Curr Drug Targets 2007 8 6 765 71 17584032
36. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models. J Meletiadis PE Verweij DT TeDorsthorst JF Meis JW Mouton, Med Mycol 2005 43 2 133 52 15832557
37. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. J Meletiadis JW Mouton JF Meis PE Verweij, Antimicrob Agents Chemother 2003 47 1 106 17 12499177
38. A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations. T Frgala O Kalous RT Proffitt CP Reynolds, Mol Cancer Ther 2007 6 3 886 97 17363483
39. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3. BA Scheven MJ van der Veen CA Damen FP Lafeber HJ Van Rijn JW Bijlsma SA Duursma, J Bone Miner Res 1995 10 6 874 80 7572311